TurboPass Announces Major Platform Upgrade Introducing Instant Income, Benefits Verification, Insurance Monitoring, and Self-Invite QR code Technology

HELOTES, TX / ACCESS Newswire / March 30, 2026 / TurboPass today announced a comprehensive upgrade to its product ...
The Manila Times

PieBox Officially Launched: Building a One-Stop AI Development Platform from "Idea to Revenue" and Reshaping Enterprise Application Generation Standards

PieBox, the one-stop AI development platform highly anticipated by the technology and developer communities, announced its ...
mobilematters.gg on MSN

Roblox promo codes (April 2026)

Roblox is a massively popular online game platform that allows you to socialize with a large community and create your own mini-games. Its rise in popularity over the past few years has meant that it ...

'What if the AI agent you just deployed was secretly working against you?': Vertex AI 'double agent' flaw exposes customer data and Google's internal code

Unit 42, Palo Alto’s cybersecurity arm, has revealed new analysis showing how an AI agent deployed in the Google Cloud ...

TFSF Ventures Ranks Best AI Venture Studios 2026 Separating Builders from Advisors

TFSF Ventures FZ-LLC has published a definitive ranking of AI venture studios operating in 2026, evaluating seven firms ...

Truelist Launches Free, Open-Source Developer Tools for Email Validation

Truelist releases 20+ free, open-source SDKs and framework integrations for email validation — Node, Python, React, ...

Blitz AI and CityView Announce Partnership to Modernize Digital Permitting and AI Plan Reviews, Starting with Naples, FL

Blitz AI and CityView partner to deliver AI automated plan reviews for local governments, improving speed and transparency, ...

Smarkets review UK: prediction markets, exchange betting & legality explained

Let’s be honest about betting exchanges. Terms like prediction markets, commission and liquidity, don’t exactly sound simple. Add in questions about legality in the UK, and it’s easy to see why so ...
The Manila Times

Alphamab Oncology Announces the Phase III Clinical Study of Anbenitamab (KN026) Combined with HB1801 as Neoadjuvant Treatment for Breast Cancer Has Met the Primary Endpoint

Alphamab Oncology (stock code: 9966.HK) today announced that HER2 bispecific antibody Anbenitamab Injection (KN026), independently developed by the Company, and co-developed with JMT-Bio Technology Co ...